Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cole

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2016
Rheumatoid Arthritis Naive T Cells Share Hypermethylation Sites With SynoviocytesBrooke Rhead, Calliope Holingue, Michael Cole, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Oncotarget|November 6, 2015
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemiaAshleigh Herriott, Susan J Tudhope, Gesa Junge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed NeuroblastomaJane Carr-Wilkinson, Kieran O'Toole, Katrina M Wood, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2021
Adjuvant Rituximab-Exploratory Trial in Young People With Graves DiseaseTim D Cheetham, Michael Cole, Mario Abinun, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group StudyGareth J Veal, Michael Cole, Julie Errington, et al.
BMC Medicine|October 2, 2025
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trialsHelen Mossop, Zoë Walmsley, Nina Wilson, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2016
Rheumatoid Arthritis Naive T Cells Share Hypermethylation Sites With SynoviocytesBrooke Rhead, Calliope Holingue, Michael Cole, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Oncotarget|November 6, 2015
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemiaAshleigh Herriott, Susan J Tudhope, Gesa Junge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed NeuroblastomaJane Carr-Wilkinson, Kieran O'Toole, Katrina M Wood, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2021
Adjuvant Rituximab-Exploratory Trial in Young People With Graves DiseaseTim D Cheetham, Michael Cole, Mario Abinun, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group StudyGareth J Veal, Michael Cole, Julie Errington, et al.
BMC Medicine|October 2, 2025
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trialsHelen Mossop, Zoë Walmsley, Nina Wilson, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.
Pageof 11